News

SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...
PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...